Product Code: TMRGL85890
Gastrointestinal Pathogen Testing Market - Scope of Report
TMR's report on the global gastrointestinal pathogen testingt market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global gastrointestinal pathogen testingt market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global gastrointestinal pathogen testingt market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the gastrointestinal pathogen testingt market.
Market Snapshot |
Market Value in 2023 | US$ 4 Bn |
Market Value in 2031 | US$ 5.2 Bn |
CAGR | 3.2% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global gastrointestinal pathogen testingt market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global gastrointestinal pathogen testingt market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global gastrointestinal pathogen testingt market.
The report delves into the competitive landscape of the global gastrointestinal pathogen testingt market. Key players operating in the global gastrointestinal pathogen testingt market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global gastrointestinal pathogen testingt market profiled in this report.
Key Questions Answered in Global gastrointestinal pathogen testingt Market Report:
- What is the sales/revenue generated by gastrointestinal pathogen testingt across all regions during the forecast period?
- What are the opportunities in the global gastrointestinal pathogen testingt market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Gastrointestinal Pathogen Testing Market - Research Objectives and Research Approach
The comprehensive report on the global gastrointestinal pathogen testingt market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global gastrointestinal pathogen testingt market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global gastrointestinal pathogen testingt market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Gastrointestinal Pathogen Testing Market
4. Market Overview
- 4.1. Overview
- 4.2. Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunities
- 4.3. Global Gastrointestinal Pathogen Testing Market Value Analysis and Forecast, 2017-2031
5. Key Insights
- 5.1. Gastrointestinal Disorders: Overview
- 5.2. Technological Advancements
- 5.3. Key Industry Events (Key Developments, Partnership, Collaborations etc.)
- 5.4. Overview of the test type conducted across each of the End users
- 5.5. COVID-19 Pandemic Impact on Industry
6. Global Gastrointestinal Pathogen Testing Market Analysis, by Pathogen Type
- 6.1. Introduction
- 6.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Pathogen Type
- 6.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Pathogen Type
- 6.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Pathogen Type
- 6.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
- 6.5.1. Bacteria
- 6.5.1.1. Molecular Tests
- 6.5.1.2. Culture
- 6.5.1.3. Biochemical Tests
- 6.5.1.4. Others
- 6.5.2. Viruses
- 6.5.2.1. Molecular Tests
- 6.5.2.2. Culture
- 6.5.2.3. Others
- 6.5.3. Parasites
- 6.5.3.1. Ova and Parasite Microscopy
- 6.5.3.2. Molecular Tests
- 6.5.3.3. Others
7. Global Gastrointestinal Pathogen Testing Market Analysis, by Test Type
- 7.1. Introduction
- 7.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Test Type
- 7.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Test Type
- 7.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Test Type
- 7.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Test Type
- 7.5.1. Molecular Tests
- 7.5.2. Culture
- 7.5.3. Biochemical Tests
- 7.5.4. Others
8. Global Gastrointestinal Pathogen Testing Market Analysis, by Panel Type
- 8.1. Introduction
- 8.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Panel Type
- 8.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Panel Type
- 8.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Panel Type
- 8.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
- 8.5.1. Syndromic Full Multiplex Panels
- 8.5.2. Others
9. Global Gastrointestinal Pathogen Testing Market Analysis, by End-user
- 9.1. Introduction
- 9.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by End-user
- 9.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by End-user
- 9.4. Global Gastrointestinal Pathogen Testing Market Analysis, by End-user
- 9.5. Global Gastrointestinal Pathogen Testing Market Forecast, by End-user
- 9.5.1. Hospitals
- 9.5.1.1. Public
- 9.5.1.2. Private
- 9.5.1.3. Others
- 9.5.2. Diagnostic Laboratories
- 9.5.3. Point-of-Care
- 9.5.4. Others
10. Global Gastrointestinal Pathogen Testing Market Analysis, by Region
- 10.1. Introduction
- 10.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Region
- 10.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Region
- 10.4. Global Gastrointestinal Pathogen Testing Market Forecast, by Region
- 10.4.1. North America
- 10.4.2. Europe
- 10.4.3. Asia Pacific
- 10.4.4. Latin America
- 10.4.5. Middle East & Africa
11. North America Gastrointestinal Pathogen Testing Market Analysis
- 11.1. Key Insights: North America Gastrointestinal Pathogen Testing Market
- 11.2. North America Gastrointestinal Pathogen Testing Market Overview
- 11.3. North America Gastrointestinal Pathogen Testing Market Forecast, by Country
- 11.3.1. U.S.
- 11.3.2. Canada
- 11.4. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
- 11.5. North America Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
- 11.5.1. Bacteria
- 11.5.1.1. Molecular Tests
- 11.5.1.2. Culture
- 11.5.1.3. Biochemical Tests
- 11.5.1.4. Others
- 11.5.2. Viruses
- 11.5.2.1. Molecular Tests
- 11.5.2.2. Culture
- 11.5.2.3. Others
- 11.5.3. Parasites
- 11.5.3.1. Ova and Parasite Microscopy
- 11.5.3.2. Molecular Tests
- 11.5.3.3. Others
- 11.6. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
- 11.7. North America Gastrointestinal Pathogen Testing Market Forecast, by Test Type
- 11.7.1. Molecular Tests
- 11.7.2. Culture
- 11.7.3. Biochemical Tests
- 11.7.4. Others
- 11.8. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
- 11.9. North America Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
- 11.9.1. Syndromic Full Multiplex Panels
- 11.9.2. Others
- 11.10. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
- 11.11. North America Gastrointestinal Pathogen Testing Market Forecast, by End-user
- 11.11.1. Hospitals
- 11.11.1.1. Public
- 11.11.1.2. Private
- 11.11.1.3. Others
- 11.11.2. Diagnostic Laboratories
- 11.11.3. Point-of-Care
- 11.11.4. Others
12. Europe Gastrointestinal Pathogen Testing Market Analysis
- 12.1. Key Insights: Europe Gastrointestinal Pathogen Testing Market
- 12.2. Europe Gastrointestinal Pathogen Testing Market Overview
- 12.3. Europe Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
- 12.3.1. Germany
- 12.3.2. U.K.
- 12.3.3. France
- 12.3.4. Italy
- 12.3.5. Spain
- 12.3.6. Rest of Europe
- 12.4. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
- 12.5. Europe Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
- 12.5.1. Bacteria
- 12.5.1.1. Molecular Tests
- 12.5.1.2. Culture
- 12.5.1.3. Biochemical Tests
- 12.5.1.4. Others
- 12.5.2. Viruses
- 12.5.2.1. Molecular Tests
- 12.5.2.2. Culture
- 12.5.2.3. Others
- 12.5.3. Parasites
- 12.5.3.1. Ova and Parasite Microscopy
- 12.5.3.2. Molecular Tests
- 12.5.3.3. Others
- 12.6. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
- 12.7. Europe Gastrointestinal Pathogen Testing Market Forecast, by Test Type
- 12.7.1. Molecular Tests
- 12.7.2. Culture
- 12.7.3. Biochemical Tests
- 12.7.4. Others
- 12.8. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
- 12.9. Europe Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
- 12.9.1. Syndromic Full Multiplex Panels
- 12.9.2. Others
- 12.10. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
- 12.11. Europe Gastrointestinal Pathogen Testing Market Forecast, by End-user
- 12.11.1. Hospitals
- 12.11.1.1. Public
- 12.11.1.2. Private
- 12.11.1.3. Others
- 12.11.2. Diagnostic Laboratories
- 12.11.3. Point-of-Care
- 12.11.4. Others
13. Asia Pacific Gastrointestinal Pathogen Testing Market Analysis
- 13.1. Key Insights: Asia Pacific Gastrointestinal Pathogen Testing Market
- 13.2. Asia Pacific Gastrointestinal Pathogen Testing Market Overview
- 13.3. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
- 13.3.1. China
- 13.3.2. Japan
- 13.3.3. India
- 13.3.4. Australia & New Zealand
- 13.3.5. Rest of Asia Pacific
- 13.4. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
- 13.5. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
- 13.5.1. Bacteria
- 13.5.1.1. Molecular Tests
- 13.5.1.2. Culture
- 13.5.1.3. Biochemical Tests
- 13.5.1.4. Others
- 13.5.2. Viruses
- 13.5.2.1. Molecular Tests
- 13.5.2.2. Culture
- 13.5.2.3. Others
- 13.5.3. Parasites
- 13.5.3.1. Ova and Parasite Microscopy
- 13.5.3.2. Molecular Tests
- 13.5.3.3. Others
- 13.6. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
- 13.7. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Test Type
- 13.7.1. Molecular Tests
- 13.7.2. Culture
- 13.7.3. Biochemical Tests
- 13.7.4. Others
- 13.8. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
- 13.9. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
- 13.9.1. Syndromic Full Multiplex Panels
- 13.9.2. Others
- 13.10. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
- 13.11. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by End-user
- 13.11.1. Hospitals
- 13.11.1.1. Public
- 13.11.1.2. Private
- 13.11.1.3. Others
- 13.11.2. Diagnostic Laboratories
- 13.11.3. Point-of-Care
- 13.11.4. Others
14. Latin America Gastrointestinal Pathogen Testing Market Analysis
- 14.1. Key Insights: Latin America Gastrointestinal Pathogen Testing Market
- 14.2. Latin America Gastrointestinal Pathogen Testing Market Overview
- 14.3. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
- 14.3.1. Brazil
- 14.3.2. Mexico
- 14.3.3. Rest of Latin America
- 14.4. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
- 14.5. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
- 14.5.1. Bacteria
- 14.5.1.1. Molecular Tests
- 14.5.1.2. Culture
- 14.5.1.3. Biochemical Tests
- 14.5.1.4. Others
- 14.5.2. Viruses
- 14.5.2.1. Molecular Tests
- 14.5.2.2. Culture
- 14.5.2.3. Others
- 14.5.3. Parasites
- 14.5.3.1. Ova and Parasite Microscopy
- 14.5.3.2. Molecular Tests
- 14.5.3.3. Others
- 14.6. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
- 14.7. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Test Type
- 14.7.1. Molecular Tests
- 14.7.2. Culture
- 14.7.3. Biochemical Tests
- 14.7.4. Others
- 14.8. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
- 14.9. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
- 14.9.1. Syndromic Full Multiplex Panels
- 14.9.2. Others
- 14.10. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
- 14.11. Latin America Gastrointestinal Pathogen Testing Market Forecast, by End-user
- 14.11.1. Hospitals
- 14.11.1.1. Public
- 14.11.1.2. Private
- 14.11.1.3. Others
- 14.11.2. Diagnostic Laboratories
- 14.11.3. Point-of-Care
- 14.11.4. Others
15. Middle East & Africa Gastrointestinal Pathogen Testing Market Analysis
- 15.1. Key Insights: Middle East & Africa Gastrointestinal Pathogen Testing Market
- 15.2. Middle East & Africa Gastrointestinal Pathogen Testing Market Overview
- 15.3. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
- 15.3.1. GCC Countries
- 15.3.2. South Africa
- 15.3.3. Rest of Middle East & Africa
- 15.4. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
- 15.5. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
- 15.5.1. Bacteria
- 15.5.1.1. Molecular Tests
- 15.5.1.2. Culture
- 15.5.1.3. Biochemical Tests
- 15.5.1.4. Others
- 15.5.2. Viruses
- 15.5.2.1. Molecular Tests
- 15.5.2.2. Culture
- 15.5.2.3. Others
- 15.5.3. Parasites
- 15.5.3.1. Ova and Parasite Microscopy
- 15.5.3.2. Molecular Tests
- 15.5.3.3. Others
- 15.6. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
- 15.7. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Test Type
- 15.7.1. Molecular Tests
- 15.7.2. Culture
- 15.7.3. Biochemical Tests
- 15.7.4. Others
- 15.8. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
- 15.9. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
- 15.9.1. Syndromic Full Multiplex Panels
- 15.9.2. Others
- 15.10. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
- 15.11. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by End-user
- 15.11.1. Hospitals
- 15.11.1.1. Public
- 15.11.1.2. Private
- 15.11.1.3. Others
- 15.11.2. Diagnostic Laboratories
- 15.11.3. Point-of-Care
- 15.11.4. Others
16. Competition Landscape
- 16.1. Market Player - Competition Matrix (by tier and size of companies)
- 16.2. Market Share Analysis, by Company (2022)
- 16.3. Company Profiles
- 16.3.1. bioMerieux SA
- 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.1.2. Product Portfolio
- 16.3.1.3. Financial Overview
- 16.3.1.4. SWOT Analysis
- 16.3.1.5. Strategic Overview
- 16.3.2. Becton, Dickinson, and Company (BD)
- 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.2.2. Product Portfolio
- 16.3.2.3. Financial Overview
- 16.3.2.4. SWOT Analysis
- 16.3.2.5. Strategic Overview
- 16.3.3. QIAGEN
- 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.3.2. Product Portfolio
- 16.3.3.3. Financial Overview
- 16.3.3.4. SWOT Analysis
- 16.3.3.5. Strategic Overview
- 16.3.4. Bio-Rad Laboratories, Inc.
- 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.4.2. Product Portfolio
- 16.3.4.3. Financial Overview
- 16.3.4.4. SWOT Analysis
- 16.3.4.5. Strategic Overview
- 16.3.5. Thermo Fisher Scientific, Inc.
- 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.5.2. Product Portfolio
- 16.3.5.3. Financial Overview
- 16.3.5.4. SWOT Analysis
- 16.3.5.5. Strategic Overview
- 16.3.6. Meridian Bioscience, Inc.
- 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.6.2. Product Portfolio
- 16.3.6.3. Financial Overview
- 16.3.6.4. SWOT Analysis
- 16.3.6.5. Strategic Overview
- 16.3.7. Cepheid (Danaher Corporation)
- 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.7.2. Product Portfolio
- 16.3.7.3. Financial Overview
- 16.3.7.4. SWOT Analysis
- 16.3.7.5. Strategic Overview
- 16.3.8. Laboratory Corporation of America Holdings
- 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.8.2. Product Portfolio
- 16.3.8.3. Financial Overview
- 16.3.8.4. SWOT Analysis
- 16.3.8.5. Strategic Overview
- 16.3.9. Illumina, Inc.
- 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.9.2. Product Portfolio
- 16.3.9.3. Financial Overview
- 16.3.9.4. SWOT Analysis
- 16.3.9.5. Strategic Overview
- 16.3.10. DiaSorin S.p.A.
- 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.10.2. Product Portfolio
- 16.3.10.3. Financial Overview
- 16.3.10.4. SWOT Analysis
- 16.3.10.5. Strategic Overview
- 16.3.11. Seegene, Inc.
- 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.11.2. Product Portfolio
- 16.3.11.3. Financial Overview
- 16.3.11.4. SWOT Analysis
- 16.3.11.5. Strategic Overview
- 16.3.12. CerTest Biotec, S.L.
- 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.12.2. Product Portfolio
- 16.3.12.3. Financial Overview
- 16.3.12.4. SWOT Analysis
- 16.3.12.5. Strategic Overview
- 16.3.13. Abbott
- 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.13.2. Product Portfolio
- 16.3.13.3. Financial Overview
- 16.3.13.4. SWOT Analysis
- 16.3.13.5. Strategic Overview
- 16.3.14. F. Hoffmann-La Roche Ltd.
- 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.14.2. Product Portfolio
- 16.3.14.3. Financial Overview
- 16.3.14.4. SWOT Analysis
- 16.3.14.5. Strategic Overview
- 16.3.15. Genova Diagnostics
- 16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.15.2. Product Portfolio
- 16.3.15.3. Financial Overview
- 16.3.15.4. SWOT Analysis
- 16.3.15.5. Strategic Overview
- 16.3.16. MicroGen DX
- 16.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.16.2. Product Portfolio
- 16.3.16.3. Financial Overview
- 16.3.16.4. SWOT Analysis
- 16.3.16.5. Strategic Overview
- 16.3.17. Quidel Corporation
- 16.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.17.2. Product Portfolio
- 16.3.17.3. Financial Overview
- 16.3.17.4. SWOT Analysis
- 16.3.17.5. Strategic Overview